Details for New Drug Application (NDA): 090212
✉ Email this page to a colleague
The generic ingredient in ADENOSINE is adenosine. There are twenty-six drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the adenosine profile page.
Pharmacology for NDA: 090212
Mechanism of Action | Adenosine Receptor Agonists |
Medical Subject Heading (MeSH) Categories for 090212
Suppliers and Packaging for NDA: 090212
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ADENOSINE | adenosine | SOLUTION;INTRAVENOUS | 090212 | ANDA | Mylan Institutional LLC | 67457-856 | 67457-856-20 | 1 VIAL in 1 CARTON (67457-856-20) / 20 mL in 1 VIAL |
ADENOSINE | adenosine | SOLUTION;INTRAVENOUS | 090212 | ANDA | Mylan Institutional LLC | 67457-857 | 67457-857-30 | 1 VIAL in 1 CARTON (67457-857-30) / 30 mL in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 60MG/20ML (3MG/ML) | ||||
Approval Date: | Mar 28, 2014 | TE: | AP | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 90MG/30ML (3MG/ML) | ||||
Approval Date: | Mar 28, 2014 | TE: | AP | RLD: | No |
Complete Access Available with Subscription